Clinical Trial Update: Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization [Phase 4]

View source ↗

Summary

This clinical trial update evaluates the curative effect of Shexiang Baoxin Pill for coronary artery disease not amenable to revascularization. It is a Phase 4 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Shexiang Baoxin Pill

Snippet

Sponsor: Jun Li | Conditions: Coronary Artery Disease(CAD) | Phase 4 | Status: UNKNOWN